JP Morgan Maintains Neutral on HCA Healthcare, Lowers Price Target to $425

Benzinga Newsdesk www.benzinga.com Negative 62.5%

Neg 62.5% Neu 0% Pos 0%

JP Morgan analyst Benjamin Rossi maintains HCA Healthcare (NYSE:HCA) with a Neutral and lowers the price target from $490 to $425.